Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harland LTG"'
Autor:
Harland, LTG
During mouse gastrulation pluripotent epiblast cells traverse the primitive streak (PS) and diversify into mesoderm and endoderm subtypes. The T-box transcription factor Eomesodermin (Eomes) is expressed during PS formation and is critical for the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::c89cd0a5bc6b72897f29a00c854a62b7
https://ora.ox.ac.uk/objects/uuid:c8ea52f5-fc46-4bff-be9c-cc75cce0a556
https://ora.ox.ac.uk/objects/uuid:c8ea52f5-fc46-4bff-be9c-cc75cce0a556
Autor:
Hernández-Martínez R; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Nowotschin S; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Harland LTG; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Kuo YY; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Theeuwes B; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Göttgens B; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Lacy E; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Hadjantonakis AK; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Anderson KV; Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 11. Date of Electronic Publication: 2024 Sep 11.
Autor:
Imaz-Rosshandler I; Department of Haematology, University of Cambridge, Cambridge CB2 0RE, UK.; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.; MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK., Rode C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK., Guibentif C; Department of Microbiology and Immunology, University of Gothenburg, 405 30 Gothenburg, Sweden., Harland LTG; Department of Haematology, University of Cambridge, Cambridge CB2 0RE, UK.; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK., Ton MN; Department of Haematology, University of Cambridge, Cambridge CB2 0RE, UK.; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK., Dhapola P; Division of Molecular Hematology, Lund Stem Cell Center, Lund University, 221 00 Lund, Sweden., Keitley D; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK., Argelaguet R; Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.; Altos Labs Cambridge Institute, Granta Park, Cambridge CB21 6GP, UK., Calero-Nieto FJ; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK., Nichols J; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK., Marioni JC; Wellcome Sanger Institute, Wellcome Genome Campus, Saffron Walden CB10 1SA, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute, Saffron Walden CB10 1SA, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., de Bruijn MFTR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK., Göttgens B; Department of Haematology, University of Cambridge, Cambridge CB2 0RE, UK.; Wellcome-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.
Publikováno v:
Development (Cambridge, England) [Development] 2024 Feb 01; Vol. 151 (3). Date of Electronic Publication: 2024 Jan 31.
A degron-based approach to manipulate Eomes functions in the context of the developing mouse embryo.
Autor:
Bisia AM; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Costello I; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Xypolita ME; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Harland LTG; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Kurbel PJ; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Bikoff EK; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom., Robertson EJ; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 31; Vol. 120 (44), pp. e2311946120. Date of Electronic Publication: 2023 Oct 23.
Autor:
Harland LTG; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Simon CS; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Senft AD; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Costello I; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Greder L; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Imaz-Rosshandler I; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK., Göttgens B; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Marioni JC; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.; Wellcome Sanger Institute, Cambridge, UK.; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Bikoff EK; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Porcher C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., de Bruijn MFTR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. marella.debruijn@imm.ox.ac.uk., Robertson EJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. elizabeth.robertson@path.ox.ac.uk.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2021 Mar; Vol. 23 (3), pp. 293.
Autor:
Harland LTG; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Simon CS; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Senft AD; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Costello I; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Greder L; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Imaz-Rosshandler I; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK., Göttgens B; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Marioni JC; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.; Wellcome Sanger Institute, Cambridge, UK.; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Bikoff EK; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Porcher C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., de Bruijn MFTR; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK. marella.debruijn@imm.ox.ac.uk., Robertson EJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. elizabeth.robertson@path.ox.ac.uk.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2021 Jan; Vol. 23 (1), pp. 61-74. Date of Electronic Publication: 2021 Jan 08.